Continuous-Flow-Based Microfluidic Systems for Therapeutic Monoclonal Antibody Production and Organ-on-a-Chip Drug Testing

Laszlo Hajba, A. Guttman

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Continuous-flow processing in the manufacturing of modern biotherapeutics represents a great potential and could significantly improve productivity and product quality as well as reduce operating costs. Microfluidic perfusion systems are not only capable for producing therapeutic proteins but also suitable for organ-on-a-chip based drug testing and toxicology studies. Integrating modular unit operations for protein purification in the microfluidic cell culture device can lead to point-of-care therapeutic protein production. The multi-organ microfluidic platforms that integrate several organ-on-a-chip microfluidic units will help in preclinical testing of drug substances and toxicological studies by producing highly reliable preclinical pharmacokinetic data. In this perspective, the current state of the art and future trends of continuous flow systems are summarized for biopharmaceutical production and organ-on-a-chip drug testing.

Original languageEnglish
Pages (from-to)118-123
Number of pages6
JournalJournal of Flow Chemistry
Volume7
Issue number3-4
DOIs
Publication statusPublished - Jul 1 2017

Fingerprint

Monoclonal antibodies
Microfluidics
Monoclonal Antibodies
Testing
Proteins
Pharmaceutical Preparations
Pharmacokinetics
Cell culture
Operating costs
Purification
Productivity
Processing

Keywords

  • cell culture
  • microfluidic perfusion system
  • Monoclonal antibody production
  • organ-on-a-chip

ASJC Scopus subject areas

  • Chemistry (miscellaneous)
  • Fluid Flow and Transfer Processes
  • Organic Chemistry

Cite this

Continuous-Flow-Based Microfluidic Systems for Therapeutic Monoclonal Antibody Production and Organ-on-a-Chip Drug Testing. / Hajba, Laszlo; Guttman, A.

In: Journal of Flow Chemistry, Vol. 7, No. 3-4, 01.07.2017, p. 118-123.

Research output: Contribution to journalArticle

@article{dcfdc5800f2c494daeb347eb03b17bbe,
title = "Continuous-Flow-Based Microfluidic Systems for Therapeutic Monoclonal Antibody Production and Organ-on-a-Chip Drug Testing",
abstract = "Continuous-flow processing in the manufacturing of modern biotherapeutics represents a great potential and could significantly improve productivity and product quality as well as reduce operating costs. Microfluidic perfusion systems are not only capable for producing therapeutic proteins but also suitable for organ-on-a-chip based drug testing and toxicology studies. Integrating modular unit operations for protein purification in the microfluidic cell culture device can lead to point-of-care therapeutic protein production. The multi-organ microfluidic platforms that integrate several organ-on-a-chip microfluidic units will help in preclinical testing of drug substances and toxicological studies by producing highly reliable preclinical pharmacokinetic data. In this perspective, the current state of the art and future trends of continuous flow systems are summarized for biopharmaceutical production and organ-on-a-chip drug testing.",
keywords = "cell culture, microfluidic perfusion system, Monoclonal antibody production, organ-on-a-chip",
author = "Laszlo Hajba and A. Guttman",
year = "2017",
month = "7",
day = "1",
doi = "10.1556/1846.2017.00014",
language = "English",
volume = "7",
pages = "118--123",
journal = "Journal of Flow Chemistry",
issn = "2062-249X",
publisher = "Akademiai Kiado",
number = "3-4",

}

TY - JOUR

T1 - Continuous-Flow-Based Microfluidic Systems for Therapeutic Monoclonal Antibody Production and Organ-on-a-Chip Drug Testing

AU - Hajba, Laszlo

AU - Guttman, A.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Continuous-flow processing in the manufacturing of modern biotherapeutics represents a great potential and could significantly improve productivity and product quality as well as reduce operating costs. Microfluidic perfusion systems are not only capable for producing therapeutic proteins but also suitable for organ-on-a-chip based drug testing and toxicology studies. Integrating modular unit operations for protein purification in the microfluidic cell culture device can lead to point-of-care therapeutic protein production. The multi-organ microfluidic platforms that integrate several organ-on-a-chip microfluidic units will help in preclinical testing of drug substances and toxicological studies by producing highly reliable preclinical pharmacokinetic data. In this perspective, the current state of the art and future trends of continuous flow systems are summarized for biopharmaceutical production and organ-on-a-chip drug testing.

AB - Continuous-flow processing in the manufacturing of modern biotherapeutics represents a great potential and could significantly improve productivity and product quality as well as reduce operating costs. Microfluidic perfusion systems are not only capable for producing therapeutic proteins but also suitable for organ-on-a-chip based drug testing and toxicology studies. Integrating modular unit operations for protein purification in the microfluidic cell culture device can lead to point-of-care therapeutic protein production. The multi-organ microfluidic platforms that integrate several organ-on-a-chip microfluidic units will help in preclinical testing of drug substances and toxicological studies by producing highly reliable preclinical pharmacokinetic data. In this perspective, the current state of the art and future trends of continuous flow systems are summarized for biopharmaceutical production and organ-on-a-chip drug testing.

KW - cell culture

KW - microfluidic perfusion system

KW - Monoclonal antibody production

KW - organ-on-a-chip

UR - http://www.scopus.com/inward/record.url?scp=85044379121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044379121&partnerID=8YFLogxK

U2 - 10.1556/1846.2017.00014

DO - 10.1556/1846.2017.00014

M3 - Article

AN - SCOPUS:85044379121

VL - 7

SP - 118

EP - 123

JO - Journal of Flow Chemistry

JF - Journal of Flow Chemistry

SN - 2062-249X

IS - 3-4

ER -